Back

Valvular heart disease in transthyretin cardiac amyloidosis

11 December 2024 (15:00 - 15:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award session - Clinical Science Valvular Heart Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Ms Camille Sarrazyn

AZORG Hospital, Aalst (Belgium)

3 More presentations in this session

Presentation thumbnail
Mitral regurgitation evolution after transcatheter tricuspid valve interventions; a sub-analysis of the TriValve registry.
Doctor F. Cannata (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Identification of risk phenogroups among patients with moderate-to-severe tricuspid regurgitation by unsupervised cluster analysis
Doctor D. Radu (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Athletic shapeshifting of the right ventricle: 3D echocardiography-derived global and regional shape analysis in elite athletes
Doctor A. Fabian (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award session - Clinical Science
Video

The Event

Event poster

EuroEcho-Imaging 2024

11 December 2024 15:00 CET
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Session
Evolving landscape in transthyretin amyloid cardiomyopathy (ATTR-CM): clinical practice and emerging treatments
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources